Year |
Citation |
Score |
2006 |
El-Zein R, Etzel CJ, Lopez MS, Gu Y, Spitz MR, Strom SS. Human sensitivity to PhIP: a novel marker for prostate cancer risk. Mutation Research. 601: 1-10. PMID 16889804 DOI: 10.1016/J.Mrfmmm.2006.05.023 |
0.546 |
|
2006 |
Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer. 107: 631-9. PMID 16802288 DOI: 10.1002/Cncr.22025 |
0.503 |
|
2005 |
Strom SS, Gu Y, Gruschkus SK, Pierce SA, Estey EH. Risk factors of myelodysplastic syndromes: a case-control study. Leukemia. 19: 1912-8. PMID 16167059 DOI: 10.1038/Sj.Leu.2403945 |
0.501 |
|
2005 |
El-Zein R, Gu Y, Sierra MS, Spitz MR, Strom SS. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 748-52. PMID 15767363 DOI: 10.1158/1055-9965.Epi-04-0236 |
0.522 |
|
2004 |
Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, Pettaway CA, Shete S, Spitz MR, Logothetis CJ. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. The Prostate. 60: 343-51. PMID 15264247 DOI: 10.1002/Pros.20060 |
0.529 |
|
2004 |
Strom SS, Gu Y, Gruschkus SK, Estey EH. Risk Factors of Myelodysplastic Syndromes (MDS): A Case-Control Study. Blood. 104: 71-71. DOI: 10.1182/Blood.V104.11.71.71 |
0.394 |
|
2004 |
Gu Y, Strom SS, Lerner S, Keating MJ. Second Cancers after CLL Diagnosis. Blood. 104: 18-18. DOI: 10.1182/Blood.V104.11.18.18 |
0.56 |
|
1998 |
Strom SS, Gu Y, Sigurdson AJ, Bailey NM, Amos CI, Spitz MR, Rodriguez MA, Liang JC. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leukemia & Lymphoma. 28: 561-6. PMID 9613986 DOI: 10.3109/10428199809058364 |
0.565 |
|
Show low-probability matches. |